AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 56 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $31 | -35.4% | 105,800 | 0.0% | 0.00% | -40.0% |
| Q4 2022 | $48 | -99.9% | 105,800 | 0.0% | 0.01% | -16.7% |
| Q3 2022 | $56,000 | +5.7% | 105,800 | 0.0% | 0.01% | +20.0% |
| Q2 2022 | $53,000 | -78.2% | 105,800 | 0.0% | 0.01% | -75.0% |
| Q1 2022 | $243,000 | -51.7% | 105,800 | 0.0% | 0.02% | -47.4% |
| Q4 2021 | $503,000 | -39.0% | 105,800 | +2.1% | 0.04% | -45.7% |
| Q3 2021 | $824,000 | +14.3% | 103,600 | 0.0% | 0.07% | +14.8% |
| Q2 2021 | $721,000 | -12.2% | 103,600 | 0.0% | 0.06% | -19.7% |
| Q1 2021 | $821,000 | +42.0% | 103,600 | +41.0% | 0.08% | +35.7% |
| Q4 2020 | $578,000 | +10.9% | 73,500 | 0.0% | 0.06% | 0.0% |
| Q3 2020 | $521,000 | +12.5% | 73,500 | +47.0% | 0.06% | +1.8% |
| Q2 2020 | $463,000 | +184.0% | 50,000 | +42.9% | 0.06% | +129.2% |
| Q1 2020 | $163,000 | -28.8% | 35,000 | +16.7% | 0.02% | -11.1% |
| Q4 2019 | $229,000 | -0.9% | 30,000 | 0.0% | 0.03% | -6.9% |
| Q3 2019 | $231,000 | +12.1% | 30,000 | 0.0% | 0.03% | +7.4% |
| Q2 2019 | $206,000 | -14.9% | 30,000 | 0.0% | 0.03% | -20.6% |
| Q1 2019 | $242,000 | +61.3% | 30,000 | +50.0% | 0.03% | +41.7% |
| Q4 2018 | $150,000 | – | 20,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 279,678 | $2,587,000 | 10.00% |
| Aisling Capital Management LP | 1,691,151 | $15,643,000 | 5.97% |
| Samsara BioCapital, LLC | 967,500 | $8,949,000 | 2.88% |
| Bain Capital Life Sciences Investors, LLC | 2,700,000 | $24,975,000 | 2.62% |
| Soleus Capital Management, L.P. | 369,852 | $3,421,000 | 1.95% |
| Nantahala Capital Management | 3,204,830 | $29,645,000 | 0.89% |
| Lion Point Capital, LP | 300,000 | $2,775,000 | 0.67% |
| Abingworth LLP | 240,500 | $2,221,000 | 0.62% |
| Sio Capital Management, LLC | 211,104 | $1,953,000 | 0.57% |
| Orbimed Advisors | 4,015,524 | $37,144,000 | 0.52% |